GCCs - Indian Pharma moves up the Value Chain...

The digital revolution is the fourth industrial revolution. It changes models, processes and whole public sectors. In many reports you will find that, in terms of digitalization, pharma is just next to the public sector, as least digitalized. Pharma just started late. There are many reasons for that – it is one of the most regulated industries with lots of sensitive data involved and many ethical aspects. But the slowed down digitalization has a lot to do with some subjective reasons. Adopting digital technologies requires changing existing models which requires a different mindset – and this is difficult to achieve. Nowadays, in the situation of a global pandemic, we see that digital communication is not only necessary to be successful but it is a must in order to adapt to the New Normality.

The customer is the one who buys a product...

India’s caesarean section debate is drifting toward polarisation. On one...

The Indian Pharmaceutical Market (IPM) was valued at Rs. 10,278 crs in the month of September 2016 clocking a strong 10% growth over same period last year (SPLY). On a MAT September basis, the industry was valued at Rs. 111,022 crores and reflected a 13% growth with volumes contributing around 40% of this growth and New Introductions playing an important role with around 38% contribution to the overall growth.

Driven by the ongoing efforts to overcome the inefficiencies...

The Semaglutide Shift: From Blockbuster to Commodity Why the $50...

In 1989, oncology in India was not a business...

Ritesh Desai has joined Standard Chartered India as Executive...

The story of Healthium is not just one of...

Driven by the ongoing efforts to overcome the inefficiencies...

The Semaglutide Shift: From Blockbuster to Commodity Why the $50...

In 1989, oncology in India was not a business...

Ritesh Desai has joined Standard Chartered India as Executive...

The story of Healthium is not just one of...

Driven by the ongoing efforts to overcome the inefficiencies...

The Semaglutide Shift: From Blockbuster to Commodity Why the $50...

In 1989, oncology in India was not a business...

Ritesh Desai has joined Standard Chartered India as Executive...

The story of Healthium is not just one of...

Driven by the ongoing efforts to overcome the inefficiencies...

The Semaglutide Shift: From Blockbuster to Commodity Why the $50...

In 1989, oncology in India was not a business...

Ritesh Desai has joined Standard Chartered India as Executive...

The story of Healthium is not just one of...